Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study
Maha Fayez Albogami,Muneer S AlJomaie,Saad Saleh Almarri,Sultan Al-Malki,Shadi Tamur,Maryam Aljaid,Abdullah Khayat,Ahmad Alzahrani,Maha Albogami,Muneer AlJomaie,Saad Almarri
DOI: https://doi.org/10.2147/ppa.s431719
2023-11-03
Patient Preference and Adherence
Abstract:Maha Fayez Albogami, 1 Muneer S AlJomaie, 2 Saad Saleh Almarri, 3 Sultan Al-Malki, 4 Shadi Tamur, 4 Maryam Aljaid, 4 Abdullah Khayat, 4 Ahmad Alzahrani 4 1 College of Medicine, Taif University, Taif, Saudi Arabia; 2 Department of Pediatrics, Taif Children Hospital, Taif, Saudi Arabia; 3 Department of Pediatrics, Ministry of Health, Taif, Saudi Arabia; 4 Department of Pediatrics, College of Medicine, Taif University, Taif, Saudi Arabia Correspondence: Ahmad Alzahrani, Email Background: Anxiety about using topical corticosteroids (TCS) for childrens among parents and caretakers is a common cause of treatment failure and an overall decline in the child's quality of life. The purpose of this study was to examine the perspectives and worries of parents of Atopic dermatitis (AD) children regarding TCS. Additionally, we investigate the degree of phobia in relation to the use of the TCS. Materials and Methods: A convenience sample of 301 parents of children who had been identified with atopic dermatitis from two hospitals in Taif city were enrolled in this study. Parents who chose to participate were sent a questionnaire measuring their level of fear of TCS using the TOPICOP© scale, which also included inquiries about their demographics and clinical characteristics. Multivariate analysis was used to determine what factors influence people's overall levels of fear. Results: The median global TOPICOP score was 66.6% (IQR 60.4– 75%), SD 12.83%, which showed that nearly two-thirds of the participants showed corticosteroid phobia. A multifactorial ANOVA model showed that parents who had a female child with AD and mothers who had experienced drug allergies had a significant influence on TOPICOP scores (P< 0.05). Conclusion: Topical corticosteroid phobia is widespread among parents of children patients with AD in Taif. Regarding the utilization of TCS, we place a strong emphasis on the significant role that physicians play as sources of reliable information and proper education. Keywords: atopic dermatitis, caregivers, steroid phobia, topical corticosteroid Atopic dermatitis (AD) is an inflammatory skin disease characterized by itching and redness in multiple skin areas. 1 The exact pathogenesis of AD is unknown, but it has been suggested that an interaction between genetic and environmental factors causes it. Environmental factors are associated with both local and systemic immune dysregulation in patients with AD who have a compromised skin barrier due to genetic predisposition. 2–4 TCS remain an important component of therapy, and when used appropriately, TCS is highly effective, has a low relapse rate, and causes few local and systemic adverse effects. However, many parents of children affected by AD had significant fear and anxiety about using it, 5,6 which causes therapeutic failures due to poor adherence. The Topical Corticosteroids phobia (TCP) may have a significant impact on the everyday activities of the parents of children patients with AD, in particular, due to the fact that the age at which AD is most common is also the age at which the parent-child bond is at its most profound. The identification of TCP is thus an essential step in treating patients with AD. 7,8 Due to rapid urbanization in recent years, the prevalence of AD has significantly increased in Saudi Arabia, which has imposed a burden on children and their caregivers and the healthcare system. 9,10 Many studies showed the phobia might be increased by the information displayed on the Internet, social media, among family, friends, and even information provided by medical professionals about the long-term use of TCS. 11–13 TOPICOP is a tool used to measure corticosteroid phobia, which has excellent psychometric properties and should be easy to use in everyday clinical practice for clinicians and researchers. 7,14 The widespread fear of steroids has made people hesitant to use TCS, which has exacerbated the disease. 15 The development of efficient health education programs that can target appropriate communities and reduce TCP depends on a thorough understanding of the specific characteristics and causes that generate fear among people regarding TCS usage. Thus this study aimed to assess the degree of local corticosteroid phobia and to assess the parent's knowledge about atopic dermatitis in Taif, Saudi Arabia. This multicenter study was conducted in two hospitals (Alhada Armed Forces hospital and Children hospital) in Taif city, Saudi Arabia. A convenience sample of 301 parents of children who suffered from AD who attended the outpatient department of these two ho -Abstract Truncated-
medicine, general & internal